The 2025 Western China (Chengdu) Biopharmaceutical and Technology Equipment Exhibition concluded successfully at the Western International Expo City. Centered on the theme “Openness · Innovation · Collaboration · Win-Win,” the event convened global leaders across biopharma R&D, manufacturing, and life science instrumentation sectors.
I. EXHIBITION HIGHLIGHTS
Optoseeker presented its flagship product portfolio:
- DropletBot® Digital Microfluidics Platform – Automated high-throughput droplet control
- OptoNeuroBot® Structured Light Projector – Neural circuit modulation system
- OptoBot®500 Opto-Microfluidic System – Multi-target cell manipulation demo
- OptoBot®1000 Single-Cell Platform – Industrial-scale bioprocessing prototype
II. TECHNICAL DEMONSTRATIONS
Optoseeker engineers conducted live showcases featuring:
- Immersive Workflow Simulation
Interactive touchscreen-guided operation of DropletBot® platform with real-time process visualization. - Precision Performance Validation
- Sub-micrometer particle manipulation accuracy (＜1μm)
- 100% target capture rate in obstacle-dense environments
- Industrial Application Scenarios
Case studies in antibody screening and CAR-T cell production.
This exhibition served not only as a validation platform for Optoseeker's technological capabilities but also accelerated:
- Southwest China market expansion with 3 provincial distributor partnerships established
- Industrial-academic collaboration advancing biopharmaceutical research and manufacturing
- Supply chain localization through Chengdu-based component production initiatives
